China: Big Pharma's Long March to End?
China's explosive growth in R&D is putting the natiion on its way to becoming the world's second-largest market by 2020
Fight or Flight?
As the old orthodoxy shatters, pharma must stand firm or leave the field.
Personalized Medicines: Implications for Pharma
Marketers will need to address not only the benefits of the therapy but also the benefits of a diagnostic assay.
Go Go Generics
They already dominate the pharmaceutical market, and now generics are poised to move into biologics and complex dosage forms.
Make Rebates Work
Process-driven managed-care rebating programs can drive profitability
From Promise to Payoff
Our sixth annual pipeline report details 44 drugs that industry will be talking about in 2010.
End the Drug Drought
The fight against cancer may be the litmus test for how regulation and private investment work together to address the disease burden.
